Active Ingredients: Montelukast Sodium
Action: Selective Leukotrienes receptor antagonist
Indications:
- Indicated in the treatment of asthma as add-on therapy in those 6 months to 5 years old patients and older with mild to moderate persistent asthma who areinadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting beta agonists provide inadequate clinical control of asthma,
- Indicated in the prophylaxis of asthma from 2 years of age and older in which the predominant component is exercise-induced bronchoconstriction.
- May also be an alternative treatment option to low dose inhaled corticosteroids for 2 to 5 years old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids.